StockData
Telix Pharmaceuticals Ltd logo

Telix Pharmaceuticals Ltd (TLX) bonds

TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Feb 20, 2026Score 3/30
$8.86−0.06 (-0.73%)

Close on Nov 17, 2026Market cap $3.00BP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Total debt
$516.39M
$11.51M due within a year
Net debt
$264.48M
After $251.91M of cash
Implied interest rate
10.77%
FY2025 interest ÷ average debt
Interest coverage
0.7×
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

Notes and loans outstanding

Individual notes, bonds and loans

Telix Pharmaceuticals's filings do not break debt down by note

The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.

See a number that looks wrong?